Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of combining suramin, paclitaxel, and carboplatin
in treating patients who have stage IIIB or stage IV non-small cell lung cancer. Drugs used
in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or
die. Combining more than one drug may kill more tumor cells.